Tolbutamide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tolbutamide, covering 2023-10-06 to 2023-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide [Phase 1]